Miho Shimizu

Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy

Takashi Wada, Kengo Furuichi, Norihiko Sakai et al. · Kidney International · 2000 · 339 citations

Medicine, Immunology, Nephrology +16

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease

Kôichi Kikuchi, Daisuke Saigusa, Yoshitomi Kanemitsu et al. · Nature Communications · 2019 · 297 citations · Full text

Medicine, Biochemistry, Nephrology +17

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD

Gerald Schulman, Tomás Berl, Gerald J. Beck et al. · Journal of the American Society of Nephrology · 2014 · 269 citations

Medicine, Nephrology, Pharmacology +15

A study to survey susceptible genetic factors responsible for troglitazone‐associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus

Ichiro Watanabe, Aiko Tomita, Miho Shimizu et al. · Clinical Pharmacology & Therapeutics · 2003 · 173 citations

Medicine, Genetics, Pharmacology +14

Gut microbiota–derived D-serine protects against acute kidney injury

Yusuke Nakade, Yasunori Iwata, Kengo Furuichi et al. · JCI Insight · 2018 · 156 citations · Full text

Life Sciences, Biochemistry, Microbiology +17